Turner James M, Pattni Sanjeev S, Appleby Richard N, Walters Julian Rf
Division of Digestive Diseases, Imperial College London, Imperial College Healthcare, London, UK.
Department of Gastroenterology, Leicester Royal Infirmary, Leicester, UK.
Frontline Gastroenterol. 2017 Oct;8(4):279-283. doi: 10.1136/flgastro-2017-100826. Epub 2017 Jun 29.
Chronic diarrhoea is a common condition, resulting from a number of different disorders. Bile acid diarrhoea, occurring in about a third of these patients, is often undiagnosed. We hypothesised that a positive diagnosis of bile acid diarrhoea would reduce the need for subsequent investigations for alternative diagnoses.
Patients previously recruited to a study of chronic diarrhoea who had selenium homocholic acid taurine (SeHCAT) testing and subsequent follow-up at our institution were identified. In a retrospective analysis, the numbers of defined investigations undertaken from the first 3 months after SeHCAT in the following 5 years were compared.
90 patients were identified with primary bile acid diarrhoea (SeHCAT retention <15%, n=36) or idiopathic diarrhoea (SeHCAT retention >15%, n=54). Follow-up had been performed on 29 and 39 subjects, respectively, with no differences in previous investigations or the last contact date. In the follow-up period, the proportions of these patients who had undergone endoscopic procedures (gastroscopy, colonoscopy and sigmoidoscopy) were the same. However, there was a higher proportion of patients in the SeHCAT-negative group who had other investigations, including imaging, physiological tests and blood tests (p=0.037). The use of cross-sectional imaging was significantly higher in this group (p=0.015) with greater proportions having CT (0.44 vs 0.10) and MRI (0.26 vs 0.07). Ultrasound use and the number of blood tests were higher in the SeHCAT-negative group whereas the SeHCAT-positive group attended more clinic appointments (p=0.013).
A positive diagnosis of bile acid diarrhoea, made by a SeHCAT test, resulted in reduced use of diagnostic investigations over the subsequent 5 years.
慢性腹泻是一种常见病症,由多种不同疾病引起。胆汁酸腹泻约占这些患者的三分之一,常未被诊断出来。我们推测胆汁酸腹泻的确诊将减少后续对其他诊断进行检查的需求。
确定先前参与慢性腹泻研究并在我们机构进行了硒代高胆酸牛磺酸(SeHCAT)检测及后续随访的患者。在一项回顾性分析中,比较了SeHCAT检测后的头3个月至随后5年期间进行的明确检查的数量。
90例患者被诊断为原发性胆汁酸腹泻(SeHCAT潴留<15%,n = 36)或特发性腹泻(SeHCAT潴留>15%,n = 54)。分别对29例和39例受试者进行了随访,既往检查或最后一次联系日期无差异。在随访期间,这些患者接受内镜检查(胃镜、结肠镜和乙状结肠镜检查)的比例相同。然而,SeHCAT阴性组中有更高比例的患者进行了其他检查,包括影像学、生理检查和血液检查(p = 0.037)。该组中横断面成像的使用显著更高(p = 0.015),进行CT(0.44对0.10)和MRI(0.26对0.07)的比例更高。SeHCAT阴性组中超声检查的使用和血液检查的次数更多,而SeHCAT阳性组就诊的门诊预约更多(p = 0.013)。
通过SeHCAT检测确诊胆汁酸腹泻,导致在随后5年中诊断性检查的使用减少。